<DOC>
	<DOCNO>NCT00372541</DOCNO>
	<brief_summary>Acute low respiratory tract infection lead cause morbidity mortality sub Saharan Africa . The World Health Organisation ( WHO ) still recommend intravenous chloramphenicol treatment severe pneumonia child age less five year . However , 20 % child fail treatment due emergence resistance bacteria . Several center use ceftriaxone , third generation cephalosporin , report efficacious treatment severe pneumonia . However high cost ceftriaxone prohibitive allow routine use resource constrain country . The purpose study compare chloramphenicol ceftriaxone treatment severe pneumonia child five . We hypothesize 92.7 % child receive daily intravenous ceftriaxone ( 75 mg/kg body weight ) 7 day , recover severe pneumonia compare 80.2 % receive intravenous chloramphenicol ( 25mg/kg body weight/dose every 6 hour 7 day ) .</brief_summary>
	<brief_title>Ceftriaxone Versus Chloramphenicol Treatment Severe Pneumonia Children</brief_title>
	<detailed_description>A recent report World health Organization show pneumonia lead cause death child less 5 year . WHO recommend intravenous Chloramphenicol 25mg/kg six hourly first line drug treatment severe pneumonia child . Ceftriaxone 75mg/kg daily second line drug . The efficacy chloramphenicol treatment severe pneumonia range 80 % -84 % , ceftriaxone range 85 % 97 % . However high cost ceftriaxone prohibitive allow routine use resource constrain country . A study compare penicillin G plus chloramphenicol ceftriaxone treatment severe pneumonia Turkey find drug equally effective normalization outcome parameter . A recent Cochrane review find randomize controlled trial compare drug treatment severe form pneumonia . The objective study compare efficacy Ceftriaxone versus Chloramphenicol treatment severe pneumonia child five year age admit Mulago hospital . This double- blind randomize control trial . Three hundred forty eight child severe pneumonia randomize receive either intravenous ceftriaxone 75mg/kg/day seven day intravenous chloramphenicol 100mg/kg/day seven day . The primary outcome mortality secondary outcome time take normalization respiratory rate , temperature oxygen saturation .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Chloramphenicol</mesh_term>
	<mesh_term>Chloramphenicol succinate</mesh_term>
	<criteria>Children age 6 month 59months cough , difficult breathe low chest indrawing Consent parent/carer Children severe Asthmatic attack Allergy study drug Diagnosis Pneumocystis JiroveciPneumonia therapeutic treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>ceftriaxone</keyword>
	<keyword>chloramphenicol</keyword>
	<keyword>severe pneumonia</keyword>
	<keyword>child</keyword>
</DOC>